
Sign up to save your podcasts
Or


This week, the FDA will make a decision on whether or not to approve the first ever treatment for achondroplasia, the most common form of dwarfism. But not everyone is celebrating. This controversial treatment is forcing parents of children with achondroplasia to grapple with an age-old question: What’s best for my child?
By KCRW, Allison Behringer4.7
19051,905 ratings
This week, the FDA will make a decision on whether or not to approve the first ever treatment for achondroplasia, the most common form of dwarfism. But not everyone is celebrating. This controversial treatment is forcing parents of children with achondroplasia to grapple with an age-old question: What’s best for my child?

578 Listeners

5,102 Listeners

1,283 Listeners

609 Listeners

665 Listeners

1,108 Listeners

7,699 Listeners

387 Listeners

17,732 Listeners

154 Listeners

20,479 Listeners

24,408 Listeners

730 Listeners

2,108 Listeners

21,854 Listeners

15,000 Listeners

3,329 Listeners

3,575 Listeners

3,527 Listeners

16,579 Listeners

5,829 Listeners

9,325 Listeners

502 Listeners

2,488 Listeners